Compulsory licensing: implications on multinational drug companies
by Vure Prasad; P.S.S. Krishna Babu
International Journal of Intellectual Property Management (IJIPM), Vol. 6, No. 4, 2013

Abstract: This article is a critical analysis of compulsory licensing provisions under the Indian Patent law with recent decisions. Compulsory licenses are basically the abrogation of an IP right - an extra-ordinary legal instrument whereby the government allows itself or a third party (typically the competitor) to have access to produce, and use or sell the IP protected product or process without the consent of the IP owner. The method here is of a descriptive-analytical type. The data has been collected from secondary sources, which include the internet, research publications and the Indian Patents Act itself. India's compulsory licensing provision is now more important than ever since India passed the revised Act. This paper makes an attempt to analyse the potential of compulsory licensing to provide affordable medicines to the common man and thereby improve the quality of life.

Online publication date: Mon, 31-Mar-2014

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Intellectual Property Management (IJIPM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com